Unity Biotechnology Inc
Change company Symbol lookup
Select an option...
UBX Unity Biotechnology Inc
EYES Second Sight Medical Products Inc
MCBS MetroCity Bankshares Inc
GNBT Generex Biotechnology Corp
XOM Exxon Mobil Corp
T AT&T Inc
BAC Bank of America Corp
VTI Vanguard Total Stock Market Index Fund ETF Shares
GE General Electric Co
AAL American Airlines Group Inc
Go

Health Care : Biotechnology | Company profile

Unity Biotechnology, Inc. is a clinical stage biotechnology company engaged in developing therapeutics to treat ageing related diseases. The Company develops therapeutics for age-associated diseases such as arthritis, vision loss, and cognitive decline. It develops a range of Senolytic medicines that eliminate senescent cells and stop the production of Senescence Associated Secretory Phenotype. Its pipelines of products that target cellular senescence are in its clinical development stage. Its lead products candidates include senolytic molecules, UBX0101 and UBX1967, designed for local treatment for the removal of accumulated senescent cells.UBX0101 is a drug candidate developed for musculoskeletal diseases targeting osteoarthritis. It is a inhibitor of the MDM2/p53 protein interaction that eliminates senescent cells. UBX1967 is targeted at ophthalmologic diseases. It is a senolytic small molecule inhibitor of specific members of the Bcl-2 family of apoptosis regulatory proteins.

Postmarket

Last Trade
Delayed
$6.08
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$6.08
Day's Change
-0.04 (-0.65%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
6.15
Day's Low
6.00
Volume
(Light)
Volume:
151,554

10-day average volume:
256,466
151,554
  • Prev Close
    6.12
  • Today's Open
    6.08
  • Day's Range
    6.00-6.15
  • Avg Vol (10-day)
    256.5K
  • Last (time)
    4:00p ET 08/20/19
  • Last (size)
    820
  • 52-Wk Range
    5.94 - 24.56
    LowHigh
  • (09/17/18 - 08/19/19)
    2.36%
  • 68.5%
  • Market Cap
    262.7M
  • Shares Outstanding
    43.2M
  • -1.97
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 72.53
  • (% of float 07/31/19)
    16.25

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.